Decades of research show the mercury-containing preservative thimerosal is safe in vaccines, but CDC's new advisory panel is ...

“In our results, a substantial proportion of infections was prevented when transmissibility was similar to that encountered in typical influenza seasons, vaccine effectiveness was within the ranges ...

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by private equity firm Nordic Capital.

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced.

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by private equity firm Nordic Capital.

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

(The Hill) – Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...